H19 (gene) (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "H19 (gene)" in English language version.

refsWebsite

Global rank English rank

50nih.gov

4^th place

39doi.org

2^nd place

12semanticscholar.org

11^th place

8^th place

5harvard.edu

18^th place

17^th place

3aacrjournals.org

8,869^th place

8,487^th place

3clinicaltrials.gov

5,225^th place

4,062^nd place

2figshare.com

5,893^rd place

3,320^th place

1ensembl.org

1,626^th place

1,007^th place

1umontpellier.fr

low place

1omim.org

4,380^th place

4,305^th place

1landesbioscience.com

low place

1web.archive.org

1^st place

1eurekah.com

low place

1archive.today

14^th place

1amjpathol.org

low place

1mdanderson.org

low place

1worldcat.org

5^th place

aacrjournals.org

cancerres.aacrjournals.org

Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (February 1996). "Loss of H19 imprinting in esophageal cancer". Cancer Res. 56 (3): 480–482. PMID 8564957.
Doyle LA, Yang W, Rishi AK, Gao Y, Ross DD (July 1996). "H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein". Cancer Res. 56 (13): 2904–2907. PMID 8674037.
Ross DD, Gao Y, Yang W, Leszyk J, Shively J, Doyle LA (December 1997). "The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen". Cancer Res. 57 (24): 5460–5464. PMID 9407950.

amjpathol.org

ajp.amjpathol.org

Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (November 1998). "H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression". Am. J. Pathol. 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. PMC 1853398. PMID 9811352. Archived from the original on 2003-09-12.

archive.today

Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (November 1998). "H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression". Am. J. Pathol. 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. PMC 1853398. PMID 9811352. Archived from the original on 2003-09-12.

clinicaltrials.gov

"Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer". ClinicalTrials.gov. U.S. National Institutes of Health. 2009-08-31. Retrieved 2010-01-14.
"Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer With Symptomatic Ascites". ClinicalTrials.gov. U.S. National Institutes of Health. 2009-12-03. Retrieved 2010-01-14.
"Phase 1/2a DTA-H19 in Patients With Unresentable Pancreatic Cancer". ClinicalTrials.gov. U.S. National Institutes of Health. 2009-11-09. Retrieved 2010-01-14.

doi.org

Gabory, et al. (2009). "H19 acts as a trans regulator of the imprinted gene network controlling growth in mice" (PDF). Development. 136 (20): 3413–3421. doi:10.1242/dev.036061. PMID 19762426.
Zhang Y, Tycko B (April 1992). "Monoallelic expression of the human H19 gene". Nat. Genet. 1 (1): 40–44. doi:10.1038/ng0492-40. PMID 1363808. S2CID 35338859.
Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (August 1992). "Parental imprinting of the human H19 gene". FEBS Lett. 309 (1): 25–28. Bibcode:1992FEBSL.309...25R. doi:10.1016/0014-5793(92)80731-U. PMID 1380925. S2CID 22194553.
Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA, Bernheim A (November 1991). "The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15". Biochem. Biophys. Res. Commun. 180 (3): 1241–1250. doi:10.1016/S0006-291X(05)81329-4. PMID 1953776.
Rotondo JC, Selvatici R, Di Domenico M, Marci R, Vesce F, Tognon M, Martini F (September 2013). "Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males". Epigenetics. 8 (9): 990–997. doi:10.4161/epi.25798. PMC 3883776. PMID 23975186.
Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda H, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (July 1995). "Establishment of functional imprinting of the H19 gene in human developing placentae". Nat. Genet. 10 (3): 318–324. doi:10.1038/ng0795-318. PMID 7670470. S2CID 34185893.
Kopf E, Bibi O, Ayesh S, et al. (August 1998). "The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region". FEBS Lett. 432 (3): 123–127. Bibcode:1998FEBSL.432..123K. doi:10.1016/S0014-5793(98)00841-2. PMID 9720909. S2CID 30015086.
Takeuchi S, Hofmann WK, Tsukasaki K, et al. (May 2007). "Loss of H19 imprinting in adult T-cell leukaemia/lymphoma". Br. J. Haematol. 137 (4): 380–381. doi:10.1111/j.1365-2141.2007.06581.x. PMID 17408396. S2CID 46427539.
Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T, Adriaenssens E (August 2005). "H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1". J. Biol. Chem. 280 (33): 29625–29636. doi:10.1074/jbc.M504033200. PMID 15985428.
Brunkow ME, Tilghman SM (June 1991). "Ectopic expression of the H19 gene in mice causes prenatal lethality". Genes Dev. 5 (6): 1092–1101. doi:10.1101/gad.5.6.1092. PMID 2044956.
Brannan CI, Dees EC, Ingram RS, Tilghman SM (January 1990). "The product of the H19 gene may function as an RNA". Mol. Cell. Biol. 10 (1): 28–36. doi:10.1128/MCB.10.1.28. PMC 360709. PMID 1688465.
Bergström R, Whitehead J, Kurukuti S, Ohlsson R (February 2007). "CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain". Cell Cycle. 6 (4): 450–454. doi:10.4161/cc.6.4.3854. PMID 17329968.
Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (September 1995). "An enhancer deletion affects both H19 and Igf2 expression". Genes Dev. 9 (17): 2079–2089. doi:10.1101/gad.9.17.2079. PMID 7544754.
Arima T, Matsuda T, Takagi N, Wake N (January 1997). "Association of IGF2 and H19 imprinting with choriocarcinoma development". Cancer Genet. Cytogenet. 93 (1): 39–47. doi:10.1016/S0165-4608(96)00221-X. PMID 9062579.
Banet G, Bibi O, Matouk I, et al. (September 2000). "Characterization of human and mouse H19 regulatory sequences". Mol. Biol. Rep. 27 (3): 157–165. doi:10.1023/A:1007139713781. PMID 11254105. S2CID 8842695.
Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A (2004). "H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium". Int. J. Gynecol. Cancer. 14 (3): 521–525. doi:10.1111/j.1048-891x.2004.014314.x. PMID 15228427. S2CID 43533877.
Adriaenssens E, Lottin S, Dugimont T, Fauquette W, Coll J, Dupouy JP, Boilly B, Curgy JJ (August 1999). "Steroid hormones modulate H19 gene expression in both mammary gland and uterus". Oncogene. 18 (31): 4460–4473. doi:10.1038/sj.onc.1202819. PMID 10442637.
Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D (December 2012). "Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity" (PDF). Cancer Research. 72 (24): 6403–6413. doi:10.1158/0008-5472.CAN-12-1155. PMID 23047867.
Moore T, Haig D (February 1991). "Genomic imprinting in mammalian development: a parental tug-of-war". Trends Genet. 7 (2): 45–49. doi:10.1016/0168-9525(91)90230-N. PMID 2035190.
Gao ZH, Suppola S, Liu J, Heikkilä P, Jänne J, Voutilainen R (March 2002). "Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors". J. Clin. Endocrinol. Metab. 87 (3): 1170–1176. doi:10.1210/jcem.87.3.8331. PMID 11889182.
Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ (November 2002). "Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells". Carcinogenesis. 23 (11): 1885–1895. doi:10.1093/carcin/23.11.1885. PMID 12419837.
Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ (May 2006). "The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis" (PDF). Cancer Res. 66 (10): 5330–5337. doi:10.1158/0008-5472.CAN-06-0037. PMID 16707459.
Elkin M, Shevelev A, Schulze E, Tykocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (October 1995). "The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma". FEBS Lett. 374 (1): 57–61. Bibcode:1995FEBSL.374...57E. doi:10.1016/0014-5793(95)01074-O. PMID 7589512. S2CID 21179965.
Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E (2007). Wölfl S (ed.). "The H19 non-coding RNA is essential for human tumor growth". PLOS ONE. 2 (9): e845. Bibcode:2007PLoSO...2..845M. doi:10.1371/journal.pone.0000845. PMC 1959184. PMID 17786216.
Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, Erdmann VA, Podeh D, Komitowski D, Quasem AS, de Groot N, Hochberg A (February 1997). "The product of the imprinted H19 gene is an oncofetal RNA". Mol. Pathol. 50 (1): 34–44. doi:10.1136/mp.50.1.34. PMC 379577. PMID 9208812.
Tanos V, Prus D, Ayesh S, Weinstein D, Tykocinski ML, De-Groot N, Hochberg A, Ariel I (July 1999). "Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer". Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1): 7–11. doi:10.1016/S0301-2115(98)00275-9. PMID 10428315.
el-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V (November 1999). "Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma". Oncogene. 18 (50): 7063–7069. doi:10.1038/sj.onc.1203192. PMID 10597307. S2CID 8775403.
Ariel I, de Groot N, Hochberg A (March 2000). "Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection". Am. J. Med. Genet. 91 (1): 46–50. doi:10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I. PMID 10751088.
Ariel I, Lustig O, Schneider T, Pizov G, Sappir M, De-Groot N, Hochberg A (February 1995). "The imprinted H19 gene as a tumor marker in bladder carcinoma". Urology. 45 (2): 335–338. doi:10.1016/0090-4295(95)80030-1. PMID 7855987.
Verhaegh GW, Verkleij L, Vermeulen SH, den Heijer M, Witjes JA, Kiemeney LA (February 2008). "Polymorphisms in the H19 Gene and the Risk of Bladder Cancer". Eur. Urol. 54 (5): 1118–1126. doi:10.1016/j.eururo.2008.01.060. PMID 18262338.
Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (November 1998). "H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression". Am. J. Pathol. 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. PMC 1853398. PMID 9811352. Archived from the original on 2003-09-12.
Kawaharata H, Hinoda Y, Itoh F, Endo T, Oikawa S, Nakazato H, Imai K (July 1997). "Decreased sensitivity of carcinoembryonic antigen cDNA-transfected cells to adriamycin". Int. J. Cancer. 72 (2): 377–382. doi:10.1002/(SICI)1097-0215(19970717)72:2<377::AID-IJC29>3.0.CO;2-B. PMID 9219849.
Mirisola V, Mora R, Esposito AI, Guastini L, Tabacchiera F, Paleari L, Amaro A, Angelini G, Dellepiane M, Pfeffer U, Salami A (August 2011). "A prognostic multigene classifier for squamous cell carcinomas of the larynx". Cancer Letters. 307 (1): 37–46. doi:10.1016/j.canlet.2011.03.013. PMID 21481529.
Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N, Hochberg A (October 2002). "Possible physiological role of H19 RNA". Mol. Carcinog. 35 (2): 63–74. doi:10.1002/mc.10075. PMID 12325036. S2CID 38724288.
Lottin S, Vercoutter-Edouart AS, Adriaenssens E, Czeszak X, Lemoine J, Roudbaraki M, Coll J, Hondermarck H, Dugimont T, Curgy JJ (February 2002). "Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA". Oncogene. 21 (10): 1625–1631. doi:10.1038/sj.onc.1205233. PMID 11896592. S2CID 29493356.
Kim KS, Lee YI (November 1997). "Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma". Cancer Lett. 119 (2): 143–148. doi:10.1016/S0304-3835(97)00264-4. PMID 9570364.
Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (May 1995). "Disruption of imprinting caused by deletion of the H19 gene region in mice". Nature. 375 (6526): 34–39. Bibcode:1995Natur.375...34L. doi:10.1038/375034a0. PMID 7536897. S2CID 2998931.
Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, de Groot N, Hochberg A (December 2000). "The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma". Mol. Pathol. 53 (6): 320–323. doi:10.1136/mp.53.6.320. PMC 1186987. PMID 11193051.
Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A, Leibovitch I (December 2008). "Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin". The Journal of Urology. 180 (6): 2379–2383. doi:10.1016/j.juro.2008.08.006. ISSN 0022-5347. PMID 18950807.

ensembl.org

May2017.archive.ensembl.org

ENSG00000288237 GRCh38: Ensembl release 89: ENSG00000130600, ENSG00000288237 – Ensembl, May 2017

eurekah.com

Szymanski M, Erdmann VA, Barciszewski J. "Eurekah - Riboregulators: An Overview". Bioscience Chapter Database. Landes Bioscience. Archived from the original on 2007-07-06. Retrieved 2008-06-06.

figshare.com

aacr.figshare.com

Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D (December 2012). "Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity" (PDF). Cancer Research. 72 (24): 6403–6413. doi:10.1158/0008-5472.CAN-12-1155. PMID 23047867.
Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ (May 2006). "The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis" (PDF). Cancer Res. 66 (10): 5330–5337. doi:10.1158/0008-5472.CAN-06-0037. PMID 16707459.

harvard.edu

ui.adsabs.harvard.edu

Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (August 1992). "Parental imprinting of the human H19 gene". FEBS Lett. 309 (1): 25–28. Bibcode:1992FEBSL.309...25R. doi:10.1016/0014-5793(92)80731-U. PMID 1380925. S2CID 22194553.
Kopf E, Bibi O, Ayesh S, et al. (August 1998). "The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region". FEBS Lett. 432 (3): 123–127. Bibcode:1998FEBSL.432..123K. doi:10.1016/S0014-5793(98)00841-2. PMID 9720909. S2CID 30015086.
Elkin M, Shevelev A, Schulze E, Tykocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (October 1995). "The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma". FEBS Lett. 374 (1): 57–61. Bibcode:1995FEBSL.374...57E. doi:10.1016/0014-5793(95)01074-O. PMID 7589512. S2CID 21179965.
Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E (2007). Wölfl S (ed.). "The H19 non-coding RNA is essential for human tumor growth". PLOS ONE. 2 (9): e845. Bibcode:2007PLoSO...2..845M. doi:10.1371/journal.pone.0000845. PMC 1959184. PMID 17786216.
Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (May 1995). "Disruption of imprinting caused by deletion of the H19 gene region in mice". Nature. 375 (6526): 34–39. Bibcode:1995Natur.375...34L. doi:10.1038/375034a0. PMID 7536897. S2CID 2998931.

landesbioscience.com

Bergström R, Whitehead J, Kurukuti S, Ohlsson R (February 2007). "CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain". Cell Cycle. 6 (4): 450–454. doi:10.4161/cc.6.4.3854. PMID 17329968.

mdanderson.org

"Breast Cell Line MCF-7". Cancer Biology - Breast Cancer Cell Line Database. University of Texas M. D. Anderson Cancer Center. Retrieved 2008-06-06.

nih.gov

pubmed.ncbi.nlm.nih.gov

Gabory, et al. (2009). "H19 acts as a trans regulator of the imprinted gene network controlling growth in mice" (PDF). Development. 136 (20): 3413–3421. doi:10.1242/dev.036061. PMID 19762426.
Zhang Y, Tycko B (April 1992). "Monoallelic expression of the human H19 gene". Nat. Genet. 1 (1): 40–44. doi:10.1038/ng0492-40. PMID 1363808. S2CID 35338859.
Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (August 1992). "Parental imprinting of the human H19 gene". FEBS Lett. 309 (1): 25–28. Bibcode:1992FEBSL.309...25R. doi:10.1016/0014-5793(92)80731-U. PMID 1380925. S2CID 22194553.
Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA, Bernheim A (November 1991). "The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15". Biochem. Biophys. Res. Commun. 180 (3): 1241–1250. doi:10.1016/S0006-291X(05)81329-4. PMID 1953776.
Rotondo JC, Selvatici R, Di Domenico M, Marci R, Vesce F, Tognon M, Martini F (September 2013). "Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males". Epigenetics. 8 (9): 990–997. doi:10.4161/epi.25798. PMC 3883776. PMID 23975186.
Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda H, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (July 1995). "Establishment of functional imprinting of the H19 gene in human developing placentae". Nat. Genet. 10 (3): 318–324. doi:10.1038/ng0795-318. PMID 7670470. S2CID 34185893.
Kopf E, Bibi O, Ayesh S, et al. (August 1998). "The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region". FEBS Lett. 432 (3): 123–127. Bibcode:1998FEBSL.432..123K. doi:10.1016/S0014-5793(98)00841-2. PMID 9720909. S2CID 30015086.
Takeuchi S, Hofmann WK, Tsukasaki K, et al. (May 2007). "Loss of H19 imprinting in adult T-cell leukaemia/lymphoma". Br. J. Haematol. 137 (4): 380–381. doi:10.1111/j.1365-2141.2007.06581.x. PMID 17408396. S2CID 46427539.
Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T, Adriaenssens E (August 2005). "H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1". J. Biol. Chem. 280 (33): 29625–29636. doi:10.1074/jbc.M504033200. PMID 15985428.
Brunkow ME, Tilghman SM (June 1991). "Ectopic expression of the H19 gene in mice causes prenatal lethality". Genes Dev. 5 (6): 1092–1101. doi:10.1101/gad.5.6.1092. PMID 2044956.
Brannan CI, Dees EC, Ingram RS, Tilghman SM (January 1990). "The product of the H19 gene may function as an RNA". Mol. Cell. Biol. 10 (1): 28–36. doi:10.1128/MCB.10.1.28. PMC 360709. PMID 1688465.
Bergström R, Whitehead J, Kurukuti S, Ohlsson R (February 2007). "CTCF regulates asynchronous replication of the imprinted H19/Igf2 domain". Cell Cycle. 6 (4): 450–454. doi:10.4161/cc.6.4.3854. PMID 17329968.
Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (September 1995). "An enhancer deletion affects both H19 and Igf2 expression". Genes Dev. 9 (17): 2079–2089. doi:10.1101/gad.9.17.2079. PMID 7544754.
Arima T, Matsuda T, Takagi N, Wake N (January 1997). "Association of IGF2 and H19 imprinting with choriocarcinoma development". Cancer Genet. Cytogenet. 93 (1): 39–47. doi:10.1016/S0165-4608(96)00221-X. PMID 9062579.
Banet G, Bibi O, Matouk I, et al. (September 2000). "Characterization of human and mouse H19 regulatory sequences". Mol. Biol. Rep. 27 (3): 157–165. doi:10.1023/A:1007139713781. PMID 11254105. S2CID 8842695.
Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A (2004). "H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium". Int. J. Gynecol. Cancer. 14 (3): 521–525. doi:10.1111/j.1048-891x.2004.014314.x. PMID 15228427. S2CID 43533877.
Adriaenssens E, Lottin S, Dugimont T, Fauquette W, Coll J, Dupouy JP, Boilly B, Curgy JJ (August 1999). "Steroid hormones modulate H19 gene expression in both mammary gland and uterus". Oncogene. 18 (31): 4460–4473. doi:10.1038/sj.onc.1202819. PMID 10442637.
Shoshani O, Massalha H, Shani N, Kagan S, Ravid O, Madar S, Trakhtenbrot L, Leshkowitz D, Rechavi G, Zipori D (December 2012). "Polyploidization of murine mesenchymal cells is associated with suppression of the long noncoding RNA H19 and reduced tumorigenicity" (PDF). Cancer Research. 72 (24): 6403–6413. doi:10.1158/0008-5472.CAN-12-1155. PMID 23047867.
Moore T, Haig D (February 1991). "Genomic imprinting in mammalian development: a parental tug-of-war". Trends Genet. 7 (2): 45–49. doi:10.1016/0168-9525(91)90230-N. PMID 2035190.
Gao ZH, Suppola S, Liu J, Heikkilä P, Jänne J, Voutilainen R (March 2002). "Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors". J. Clin. Endocrinol. Metab. 87 (3): 1170–1176. doi:10.1210/jcem.87.3.8331. PMID 11889182.
Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (February 1996). "Loss of H19 imprinting in esophageal cancer". Cancer Res. 56 (3): 480–482. PMID 8564957.
Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ (November 2002). "Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells". Carcinogenesis. 23 (11): 1885–1895. doi:10.1093/carcin/23.11.1885. PMID 12419837.
Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ (May 2006). "The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis" (PDF). Cancer Res. 66 (10): 5330–5337. doi:10.1158/0008-5472.CAN-06-0037. PMID 16707459.
Elkin M, Shevelev A, Schulze E, Tykocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (October 1995). "The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma". FEBS Lett. 374 (1): 57–61. Bibcode:1995FEBSL.374...57E. doi:10.1016/0014-5793(95)01074-O. PMID 7589512. S2CID 21179965.
Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E (2007). Wölfl S (ed.). "The H19 non-coding RNA is essential for human tumor growth". PLOS ONE. 2 (9): e845. Bibcode:2007PLoSO...2..845M. doi:10.1371/journal.pone.0000845. PMC 1959184. PMID 17786216.
Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, Erdmann VA, Podeh D, Komitowski D, Quasem AS, de Groot N, Hochberg A (February 1997). "The product of the imprinted H19 gene is an oncofetal RNA". Mol. Pathol. 50 (1): 34–44. doi:10.1136/mp.50.1.34. PMC 379577. PMID 9208812.
Tanos V, Prus D, Ayesh S, Weinstein D, Tykocinski ML, De-Groot N, Hochberg A, Ariel I (July 1999). "Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer". Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1): 7–11. doi:10.1016/S0301-2115(98)00275-9. PMID 10428315.
el-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V (November 1999). "Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma". Oncogene. 18 (50): 7063–7069. doi:10.1038/sj.onc.1203192. PMID 10597307. S2CID 8775403.
Doyle LA, Yang W, Rishi AK, Gao Y, Ross DD (July 1996). "H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein". Cancer Res. 56 (13): 2904–2907. PMID 8674037.
Ariel I, de Groot N, Hochberg A (March 2000). "Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection". Am. J. Med. Genet. 91 (1): 46–50. doi:10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I. PMID 10751088.
Ariel I, Lustig O, Schneider T, Pizov G, Sappir M, De-Groot N, Hochberg A (February 1995). "The imprinted H19 gene as a tumor marker in bladder carcinoma". Urology. 45 (2): 335–338. doi:10.1016/0090-4295(95)80030-1. PMID 7855987.
Verhaegh GW, Verkleij L, Vermeulen SH, den Heijer M, Witjes JA, Kiemeney LA (February 2008). "Polymorphisms in the H19 Gene and the Risk of Bladder Cancer". Eur. Urol. 54 (5): 1118–1126. doi:10.1016/j.eururo.2008.01.060. PMID 18262338.
Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (November 1998). "H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression". Am. J. Pathol. 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. PMC 1853398. PMID 9811352. Archived from the original on 2003-09-12.
Ross DD, Gao Y, Yang W, Leszyk J, Shively J, Doyle LA (December 1997). "The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen". Cancer Res. 57 (24): 5460–5464. PMID 9407950.
Kawaharata H, Hinoda Y, Itoh F, Endo T, Oikawa S, Nakazato H, Imai K (July 1997). "Decreased sensitivity of carcinoembryonic antigen cDNA-transfected cells to adriamycin". Int. J. Cancer. 72 (2): 377–382. doi:10.1002/(SICI)1097-0215(19970717)72:2<377::AID-IJC29>3.0.CO;2-B. PMID 9219849.
Mirisola V, Mora R, Esposito AI, Guastini L, Tabacchiera F, Paleari L, Amaro A, Angelini G, Dellepiane M, Pfeffer U, Salami A (August 2011). "A prognostic multigene classifier for squamous cell carcinomas of the larynx". Cancer Letters. 307 (1): 37–46. doi:10.1016/j.canlet.2011.03.013. PMID 21481529.
Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N, Hochberg A (October 2002). "Possible physiological role of H19 RNA". Mol. Carcinog. 35 (2): 63–74. doi:10.1002/mc.10075. PMID 12325036. S2CID 38724288.
Lottin S, Vercoutter-Edouart AS, Adriaenssens E, Czeszak X, Lemoine J, Roudbaraki M, Coll J, Hondermarck H, Dugimont T, Curgy JJ (February 2002). "Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA". Oncogene. 21 (10): 1625–1631. doi:10.1038/sj.onc.1205233. PMID 11896592. S2CID 29493356.
Kim KS, Lee YI (November 1997). "Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma". Cancer Lett. 119 (2): 143–148. doi:10.1016/S0304-3835(97)00264-4. PMID 9570364.
Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (May 1995). "Disruption of imprinting caused by deletion of the H19 gene region in mice". Nature. 375 (6526): 34–39. Bibcode:1995Natur.375...34L. doi:10.1038/375034a0. PMID 7536897. S2CID 2998931.
Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, de Groot N, Hochberg A (December 2000). "The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma". Mol. Pathol. 53 (6): 320–323. doi:10.1136/mp.53.6.320. PMC 1186987. PMID 11193051.
Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A, Leibovitch I (December 2008). "Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin". The Journal of Urology. 180 (6): 2379–2383. doi:10.1016/j.juro.2008.08.006. ISSN 0022-5347. PMID 18950807.

ncbi.nlm.nih.gov

"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"H19: imprinted maternally expressed transcript (non-protein coding) (Homo sapiens)". Entrez Gene. National Center for Biotechnology Information. Retrieved 2008-06-06.
Rotondo JC, Selvatici R, Di Domenico M, Marci R, Vesce F, Tognon M, Martini F (September 2013). "Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males". Epigenetics. 8 (9): 990–997. doi:10.4161/epi.25798. PMC 3883776. PMID 23975186.
Brannan CI, Dees EC, Ingram RS, Tilghman SM (January 1990). "The product of the H19 gene may function as an RNA". Mol. Cell. Biol. 10 (1): 28–36. doi:10.1128/MCB.10.1.28. PMC 360709. PMID 1688465.
Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E (2007). Wölfl S (ed.). "The H19 non-coding RNA is essential for human tumor growth". PLOS ONE. 2 (9): e845. Bibcode:2007PLoSO...2..845M. doi:10.1371/journal.pone.0000845. PMC 1959184. PMID 17786216.
Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, Erdmann VA, Podeh D, Komitowski D, Quasem AS, de Groot N, Hochberg A (February 1997). "The product of the imprinted H19 gene is an oncofetal RNA". Mol. Pathol. 50 (1): 34–44. doi:10.1136/mp.50.1.34. PMC 379577. PMID 9208812.
Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ (November 1998). "H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression". Am. J. Pathol. 153 (5): 1597–1607. doi:10.1016/S0002-9440(10)65748-3. PMC 1853398. PMID 9811352. Archived from the original on 2003-09-12.
Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, de Groot N, Hochberg A (December 2000). "The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma". Mol. Pathol. 53 (6): 320–323. doi:10.1136/mp.53.6.320. PMC 1186987. PMID 11193051.

omim.org

Online Mendelian Inheritance in Man (OMIM): H19 Gene - 103280

semanticscholar.org

api.semanticscholar.org

Zhang Y, Tycko B (April 1992). "Monoallelic expression of the human H19 gene". Nat. Genet. 1 (1): 40–44. doi:10.1038/ng0492-40. PMID 1363808. S2CID 35338859.
Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N, Hochberg A (August 1992). "Parental imprinting of the human H19 gene". FEBS Lett. 309 (1): 25–28. Bibcode:1992FEBSL.309...25R. doi:10.1016/0014-5793(92)80731-U. PMID 1380925. S2CID 22194553.
Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda H, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (July 1995). "Establishment of functional imprinting of the H19 gene in human developing placentae". Nat. Genet. 10 (3): 318–324. doi:10.1038/ng0795-318. PMID 7670470. S2CID 34185893.
Kopf E, Bibi O, Ayesh S, et al. (August 1998). "The effect of retinoic acid on the activation of the human H19 promoter by a 3' downstream region". FEBS Lett. 432 (3): 123–127. Bibcode:1998FEBSL.432..123K. doi:10.1016/S0014-5793(98)00841-2. PMID 9720909. S2CID 30015086.
Takeuchi S, Hofmann WK, Tsukasaki K, et al. (May 2007). "Loss of H19 imprinting in adult T-cell leukaemia/lymphoma". Br. J. Haematol. 137 (4): 380–381. doi:10.1111/j.1365-2141.2007.06581.x. PMID 17408396. S2CID 46427539.
Banet G, Bibi O, Matouk I, et al. (September 2000). "Characterization of human and mouse H19 regulatory sequences". Mol. Biol. Rep. 27 (3): 157–165. doi:10.1023/A:1007139713781. PMID 11254105. S2CID 8842695.
Tanos V, Ariel I, Prus D, De-Groot N, Hochberg A (2004). "H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium". Int. J. Gynecol. Cancer. 14 (3): 521–525. doi:10.1111/j.1048-891x.2004.014314.x. PMID 15228427. S2CID 43533877.
Elkin M, Shevelev A, Schulze E, Tykocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (October 1995). "The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma". FEBS Lett. 374 (1): 57–61. Bibcode:1995FEBSL.374...57E. doi:10.1016/0014-5793(95)01074-O. PMID 7589512. S2CID 21179965.
el-Naggar AK, Lai S, Tucker SA, Clayman GL, Goepfert H, Hong WK, Huff V (November 1999). "Frequent loss of imprinting at the IGF2 and H19 genes in head and neck squamous carcinoma". Oncogene. 18 (50): 7063–7069. doi:10.1038/sj.onc.1203192. PMID 10597307. S2CID 8775403.
Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N, Hochberg A (October 2002). "Possible physiological role of H19 RNA". Mol. Carcinog. 35 (2): 63–74. doi:10.1002/mc.10075. PMID 12325036. S2CID 38724288.
Lottin S, Vercoutter-Edouart AS, Adriaenssens E, Czeszak X, Lemoine J, Roudbaraki M, Coll J, Hondermarck H, Dugimont T, Curgy JJ (February 2002). "Thioredoxin post-transcriptional regulation by H19 provides a new function to mRNA-like non-coding RNA". Oncogene. 21 (10): 1625–1631. doi:10.1038/sj.onc.1205233. PMID 11896592. S2CID 29493356.
Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (May 1995). "Disruption of imprinting caused by deletion of the H19 gene region in mice". Nature. 375 (6526): 34–39. Bibcode:1995Natur.375...34L. doi:10.1038/375034a0. PMID 7536897. S2CID 2998931.

umontpellier.fr

hal.umontpellier.fr

Gabory, et al. (2009). "H19 acts as a trans regulator of the imprinted gene network controlling growth in mice" (PDF). Development. 136 (20): 3413–3421. doi:10.1242/dev.036061. PMID 19762426.

web.archive.org

Szymanski M, Erdmann VA, Barciszewski J. "Eurekah - Riboregulators: An Overview". Bioscience Chapter Database. Landes Bioscience. Archived from the original on 2007-07-06. Retrieved 2008-06-06.

worldcat.org

search.worldcat.org

Sidi AA, Ohana P, Benjamin S, Shalev M, Ransom JH, Lamm D, Hochberg A, Leibovitch I (December 2008). "Phase I/II Marker Lesion Study of Intravesical BC-819 DNA Plasmid in H19 Over Expressing Superficial Bladder Cancer Refractory to Bacillus Calmette-Guerin". The Journal of Urology. 180 (6): 2379–2383. doi:10.1016/j.juro.2008.08.006. ISSN 0022-5347. PMID 18950807.